Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

NCT06575738 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Adolescent Obesity
Body-Weight Trajectory
Weight Loss Trajectory
Bariatric Surgery
Anti-obesity Agents

Interventions

DRUG: Injectable semaglutide
BEHAVIORAL: Standard postoperative care

Sponsor

University of Colorado, Denver

Collaborators

[object Object]